A prospective study to evaluate the effect of an anti-adhesion agent (Guardix-SG) on the range of shoulder motion after breast cancer resectio
Not Applicable
Terminated
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0003386
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- Female
- Target Recruitment
- 192
Inclusion Criteria
1. Adults over 20 years old
2. Patients diagnosed with breast cancer
3. Patients with breast cancer who underwent modified radical mastectomy or breast conserving surgery and performed axillary lymph node dissection
(Including patients who underwent preoperative chemotherapy and those who underwent axillary lymph node dissection during surgery)
Exclusion Criteria
1. Stage 0
2. Stage IV
3. Patients undergoing sentinel node biopsy alone
4. Reconstruction Patient
5. Pre-operative other shoulder disease with shoulder disability
6. Previous history of ipsilateral breast or axilla
7. Patients who are pregnant or lactating
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method shoulder ROM(range of motion);Laboratory test-WBC, Neubrophil;draunge after surgery;Adverse Event, expected side effects
- Secondary Outcome Measures
Name Time Method DASH(disavility of the arm, shoulder and hand);VAS(visual analogue scale);lymphatic edema assessed using body composition analysis